Katherine Conger is a Process Engineer II at Vor Bio, currently focusing on clinical MSAT and Tech Transfer. Prior to this role, Katherine worked at Merck as an Associate Specialist Engineering, particularly on the Gardasil Expansion Project - DS3 Purification. Katherine also has experience as an Engineering Technician at Terumo Blood and Cell Technologies and as a Research Assistant at Colorado State University, where Katherine studied autophagy inhibition in mammalian cancer cells. Katherine holds a Bachelor of Science in Chemical and Biological Engineering and Biomedical Engineering from Colorado State University.
January 1, 2024 - present
January 1, 2023
November, 2021